2m 2m 2m 2m 2m 2m 2m
Editas Medicine (EDIT)
NASDAQ
$2.43-$0.07 (-2.99%)
Price as of Nov 11, 2026 7:30 PM EST- $384.7MMarket Cap
- -5.83%1-Year Change
- BiotechnologyIndustry
Editas Medicine (EDIT)
$2.43-$0.07 (-2.99%)
EDIT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.50 | ||
Change | -$0.24 (-8.91%) | ||
Open | $2.70 | ||
High | $2.75 | ||
Low | $2.48 | ||
Previous Close | $2.75 | ||
Volume | 1,589,941 | ||
30-Day Average Volume | 2,149,267 | ||
1-Week Change | -3.65% | ||
1-Month Change | -13.62% | ||
1-Year Change | -5.83% | ||
3-Year Change | -67.34% | ||
5-Year Change | -93.39% | ||
Fundamentals | |||
Shares Outstanding | 153.6M | ||
Total Assets | $219.4M | ||
Market Cap | $384.7M | ||
Enterprise Value | $348.4M | ||
Period: QTR TTM FY | |||
Revenue | $10.4M | ||
Net Income | -$23.4M | ||
Free Cash Flow | -$21.2M | ||
EBIT | -$22.3M | ||
EBITDA | -$21.9M | ||
Net Working Capital | $130.4M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | 34 | ||
P/B | 5 | ||
P/E | -17 | ||
PEG | N/A | ||
Price/Free Cash Flow | -18 | ||
Price/Operating Cash Flow | -18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue